According to a survey carried out in five European countries in 2020, almost 70 percent of women who were eligible for hormone therapy (HT) in Spain were adverse to taking the medication. Over a fifth of respondents in Germany said they were HT contraindicated which meant they were advised against using it due to certain conditions.
Feelings towards receiving hormone therapy among those with VMS due to the menopause in France, Germany, Italy, Spain, and the UK as of 2020
Adjust the presentation of the statistic and data points.
Share the statistic on social media channels or embed the statistic in your
website using "Embed Code", where available.
Cite this statistic and select one of the following formats: APA, Chicago, Harvard, MLA & Bluebook.
Print the statistic including description and metadata.
Chart type
Feelings towards receiving hormone therapy among those with VMS due to the menopause in France, Germany, Italy, Spain, and the UK as of 2020
Share this statistic
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Expanded meanings:
- HT contraindicated: Issues such as vaginal bleeding, metastatic solid tumor, tumor without metastasis, angina pectoris, myocardial infarction, thrombosis. coagulated blood clotting disorder, liver disease.
- Caution required at HT initiation - Conditions requiring a cardiovascular or breast cancer evaluation before HT, current smoker, BMI overweight, family or personal history of breast cancer, history of migraine, diabetes, and elevated cholesterol/hyperlipidemia.
Learn more about how Statista can support your business.
Elsevier. (June 23, 2022). Feelings towards receiving hormone therapy among those with VMS due to the menopause in France, Germany, Italy, Spain, and the UK as of 2020 [Graph]. In Statista. Retrieved April 05, 2025, from https://www.statista.com/statistics/1366300/interest-in-taking-ht-for-menopause-in-europe/
Elsevier. "Feelings towards receiving hormone therapy among those with VMS due to the menopause in France, Germany, Italy, Spain, and the UK as of 2020." Chart. June 23, 2022. Statista. Accessed April 05, 2025. https://www.statista.com/statistics/1366300/interest-in-taking-ht-for-menopause-in-europe/
Elsevier. (2022). Feelings towards receiving hormone therapy among those with VMS due to the menopause in France, Germany, Italy, Spain, and the UK as of 2020. Statista. Statista Inc.. Accessed: April 05, 2025. https://www.statista.com/statistics/1366300/interest-in-taking-ht-for-menopause-in-europe/
Elsevier. "Feelings towards Receiving Hormone Therapy among Those with Vms Due to The Menopause in France, Germany, Italy, Spain, and The Uk as of 2020." Statista, Statista Inc., 23 Jun 2022, https://www.statista.com/statistics/1366300/interest-in-taking-ht-for-menopause-in-europe/
Elsevier, Feelings towards receiving hormone therapy among those with VMS due to the menopause in France, Germany, Italy, Spain, and the UK as of 2020 Statista, https://www.statista.com/statistics/1366300/interest-in-taking-ht-for-menopause-in-europe/ (last visited April 05, 2025)
Feelings towards receiving hormone therapy among those with VMS due to the menopause in France, Germany, Italy, Spain, and the UK as of 2020 [Graph], Elsevier, June 23, 2022. [Online]. Available: https://www.statista.com/statistics/1366300/interest-in-taking-ht-for-menopause-in-europe/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
